GcMaf Researches

Autism & MAF as a Potential Immune Development Protocol

  1. Autism and Macrophage Stimulation
  2. Autism and the leaky gut
  3. Autism treatment strategies
  4. Autistic disorder and viral infections
  5. Common Sense About Autism Spectrum Disorders
  6. Debunking the lamestream view of autism
  7. Ethics in Autism Care
  8. Genome
  9. Gluten and Casein
  10. Immune dysfunction in autism
  11. Initial Observations of Elevated Nagalase Activity Associated with Autism and Observed Reductions from GC Protein
  12. Initial Observations of elevated Nagalase activity associated with Autism and observed reductions from GcMAF
  13. Low methylation levels associated with autism
  14. More on Viral Persistence in a Subgroup of Autism
  15. Parasites
  16. Starting MAF
  17. Toxins in the home

Cancer & MAF

  1. Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation
  2. Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients.
  3. Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer.
  4. Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients.
  5. Immunotherapy of BALB.c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor
  6. Anti tumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.
  7. Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis
  8. Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice
  9. Effect of salivary gland adenocarcinoma cell-derived alpha-N-acetylgalactosaminidase on the bioactivity of macrophage activating factor
  10. Pancreatic carcinogenesis apoptosis and angiogenesis.
  11. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor
  12. Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor
  13. Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor
  14. Glycosylation status of vitamin D binding protein in cancer patients
  15. Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells
  16. MAF is associated with the formation of chemical messenger pathways
  17. Effects of vitamin D-binding protein-derived macrophage-activating factor on human breast cancer cells.
  18. Vitamin D-binding protein-derived MAF, and prostate cancer.

Leave a comment